Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 1

Status

Completed 4Unknown 3

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Genitourinary 2Breast 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Pain 1Inflammation 1Esophageal Neoplasms 1Emergence Delirium 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Sufentanil × Gastrointestinal × Clear all
NCT06041425 2024-02-28

The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE

The First Affiliated Hospital with Nanjing Medical University

Phase 4 Completed
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Inflammation, Pain

NCT05596071 2022-10-27

POD

Zhejiang Cancer Hospital

Phase NA Completed
130 enrolled
Gastrointestinal

Emergence Delirium, Stomach Neoplasms

NCT03185403 2017-06-14

HEMOBLOC

University Hospital, Lille

Phase NA Completed
54 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01759706 2014-12-05

Safety and Feasibility Study of Enhanced Recovery in Pancreaticoduodenectomy

Università Vita-Salute San Raffaele

Phase NA Completed
123 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡